Please wait a minute...
Journal of Neurorestoratology  2015, Vol. 3 Issue (1): 63-72    doi: 10.2147/JN.S74142
Review     
Clinical neurorestorative progress in stroke
Liyan Qiao1,*, Jun Lu2,*, Hongyun Huang3-5
1Department of Neurology, Tsinghua University Yuquan Hospital,;
2Department of Emergency, 2nd Artillery Hospital,;
3Center of Neurorestoratology, Beijing Rehabilitation Hospital, Capital Medical University,;
4Beijing Hongtianji Neuroscience Academy, Beijing,;
5Neuroscience Institute of Taishan Medical University, Shandong, People's Republic of China
Download: PDF (220 KB)     
Export: BibTeX | EndNote (RIS)      

Abstract  Stroke is the second most common single cause of death worldwide, with over five million deaths per year globally. So far, conventional therapy has failed to restore neurological function poststroke. Neurorestorative strategy has provided therapeutic benefit for the treatment of stroke. This review outlines the clinical advances, in which cell-based neurorestorative strategies offer the broadest range of potential treatments for stroke.

Key wordsstroke      cerebral infarction      treatment      neurorestorative strategy      neurological function recovery      cell therapy     
Published: 26 December 2015
Corresponding Authors: Liyan Qiao, Department of Neurology, Tsinghua University Yuquan Hospital, No 5 Shijingshan Road, Beijing, People's Republic of China, Tel +86 10 8825 5293, Email qiaoliyan2000@aliyun.com;Hongyun Huang, Beijing Hongtianji Neuroscience Academy, Lingxiu Building, No 1 Gucheng Street, Beijing, 100143, People's Republic of China, Tel +86 139 1011 6608, Email hongyunh@gmail.com; *These authors are co-first authors   
Cite this article:

Liyan Qiao, Jun Lu, Hongyun Huang. Clinical neurorestorative progress in stroke. Journal of Neurorestoratology, 2015, 3: 63-72.

URL:

http://jnr.tsinghuajournals.com/10.2147/JN.S74142     OR     http://jnr.tsinghuajournals.com/Y2015/V3/I1/63

1. Victor M, Ropper AH.Adams and Victor’s Principle of Neurology. 7th ed. New York: McGraw-Hill; 2001.
2. Howard G, Goff DC.Population shifts and the future of stroke: forecasts of the future burden of stroke.Ann N Y Acad Sci. 2012;1268:14-20.
3. Kirkman MA, Citerio G, Smith M.The intensive care management of acute ischemic stroke: an overview.Intensive Care Med. 2014;40(5):640-653.
4. Gopurappilly R, Pal R, Mamidi MK, Dey S, Bhonde R, Das AK.Stem cells in stroke repair: current success and future prospects.CNS Neurol Disord Drug Targets. 2011;10(6):741-756.
5. Green AR, Ashwood T.Free radical trapping as a therapeutic approach to neuroprotection in stroke: experimental and clinical studies with NXY-059 and free radical scavengers.Curr Drug Targets CNS Neurol Disord. 2005;4(2):109-118.
6. Diener HC, Lees KR, Lyden P, et al; SAINT I and II Investigators. NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II trials.Stroke. 2008;39(6):1751-1758.
7. Shuaib A, Lees KR, Lyden P, et al; SAINT II Trial Investigators. NXY-059 for the treatment of acute ischemic stroke.N Engl J Med. 2007;357(6):562-571.
8. Parnham MJ, Sies H.The early research and development of ebselen.Biochem Pharmacol. 2013;86(9):1248-1253.
9. Azad GK, Tomar RS.Ebselen, a promising antioxidant drug: mechanisms of action and targets of biological pathways.Mol Biol Rep. 2014;41(8):4865-4879.
10. He M, Xing S, Yang B, et al.Ebselen attenuates oxidative DNA damage and enhances its repair activity in the thalamus after focal cortical infarction in hypertensive rats.Brain Res. 2007;1181:83-92.
11. Wu HY, Tang Y, Gao LY, et al.The synergetic effect of edaravone and borneol in the rat model of ischemic stroke.Eur J Pharmacol. 2014;740:522-531.
12. Ishibashi A, Yoshitake Y, Adachi H.Investigation of effect of edaravone on ischemic stroke.Kurume Med J. 2013;60(2):53-57.
13. Wu S, Sena E, Egan K, Macleod M, Mead G.Edaravone improves functional and structural outcomes in animal models of focal cerebral ischemia: a systematic review.Int J Stroke. 2014;9(1):101-106.
14. Takenaka K, Kato M, Yamauti K, Hayashi K.Simultaneous administration of recombinant tissue plasminogen activator and edaravone in acute cerebral ischemic stroke patients.J Stroke Cerebrovasc Dis. 2014;23(10):2748-2752.
15. Ogden KK, Traynelis SF.New advances in NMDA receptor pharmacology.Trends Pharmacol Sci. 2011;32(12):726-733.
16. Kalia LV, Kalia SK, Salter MW.NMDA receptors in clinical neurology: excitatory times ahead.Lancet Neurol. 2008;7(8):742-755.
17. Dhawan J, Benveniste H, Luo Z, Nawrocky M, Smith SD, Biegon A.A new look at glutamate and ischemia: NMDA agonist improves long-term functional outcome in a rat model of stroke.Future Neurol. 2011;6(6):823-834.
18. Diener HC, Schneider D, Lampl Y, Bornstein NM, Kozak A, Rosenberg G.DP-b99, a membrane-activated metal ion chelator, as neuroprotective therapy in ischemic stroke.Stroke. 2008;39(6):1774-1778.
19. Rosenberg G, Bornstein N, Diener HC, Gorelick PB, Shuaib A, Lees K; MACSI investigators. The membrane-activated chelator stroke intervention (MACSI) trial of DP-b99 in acute ischemic stroke: a randomized, double-blind, placebo-controlled, multinational pivotal phase III study.Int J Stroke. 2011;6(4):362-367.
20. Lees KR, Bornstein N, Diener HC, Gorelick PB, Rosenberg G, Shuaib A; MACSI Investigators.Results of membrane-activated chelator stroke intervention randomized trial of DP-b99 in acute ischemic stroke.Stroke. 2013;44(3):580-584.
21. Kohler E, Prentice DA, Bates TR, et al.Intravenous minocycline in acute stroke: a randomized, controlled pilot study and meta-analysis.Stroke. 2013;44(9):2493-2499.
22. Lampl Y, Boaz M, Gilad R, et al.Minocycline treatment in acute stroke: an open-label, evaluator-blinded study.Neurology. 2007;69(14):1404-1410.
23. Padma Srivastava MV, Bhasin A, Bhatia R, et al.Efficacy of minocycline in acute ischemic stroke: a single-blinded, placebo-controlled trial.Neurol India. 2012;60(1):23-28.
24. Kalladka D, Muir KW.Brain repair: cell therapy in stroke.Stem Cells Cloning. 2014;7:31-44.
25. England TJ, Gibson CL, Bath PM.Granulocyte-colony stimulating factor in experimental stroke and its effects on infarct size and functional outcome: a systematic review.Brain Res Rev. 2009;62(1):71-82.
26. Abe K, Yamashita T, Takizawa S, Kuroda S, Kinouchi H, Kawahara N.Stem cell therapy for cerebral ischemia: from basic science to clinical applications.J Cereb Blood Flow Metab. 2012;32(7):1317-1331.
27. Shyu WC, Lin SZ, Lee CC, Liu DD, Li H.Granulocyte colony-stimulating factor for acute ischaemic stroke: a randomized controlled trial.CMAJ. 2006;174:927-933.
28. Zhang JJ, Deng M, Zhang Y, et al.A short-term assessment of recombinant granulocyte-stimulating factor (RHG-CSF) in treatment of acute cerebral infarction.Cerebrovasc Dis. 2006;22:323.
29. Sprigg N, Bath PM, Zhao L, et al.Granulocyte-colony stimulating factor mobilises bone marrow stem cells in patients with subacute ischemic stroke: the STEMS pilot randomised controlled trial.Stroke. 2006;37:2979-2983.
30. Moriya Y, Mizuma A, Uesugi T, et al.Phase I study of intravenous low-dose granulocyte colony-stimulating factor in acute and subacute ischemic stroke.J Stroke Cerebrovasc Dis. 2013;22(7):1088-1097.
31. England TJ, Abaei M, Auer DP, et al.Granulocyte-colony stimulating factor for mobilizing bone marrow stem cells in subacute stroke: the stem cell trial of recovery enhancement after stroke 2 randomized controlled trial.Stroke. 2012;43(2):405-411.
32. Ringelstein EB, Thijs V, Norrving B, et al; AXIS 2 Investigators. Granulocyte colony-stimulating factor in patients with acute ischemic stroke: results of the AX200 for ischemic stroke trial.Stroke. 2013;44(10):2681-2687.
33. Mendonça ML, Freitas GR, Silva SA, et al.Safety of intra-arterial autologous bone marrow mononuclear cell transplantation for acute ischemic stroke.Arq Bras Cardiol. 2006;86(1):52-55.
34. Moniche F, Gonzalez A, Gonzalez-Marcos JR, et al.Intra-arterial bone marrow mononuclear cells in ischemic stroke: a pilot clinical trial.Stroke. 2012;43(8):2242-2244.
35. Friedrich MA, Martins MP, Araújo MD, et al.Intra-arterial infusion of autologous bone marrow mononuclear cells in patients with moderate to severe middle cerebral artery acute ischemic stroke.Cell Transplant. 2012;21(Suppl 1):S13-S21.
36. Savitz SI, Misra V, Kasam M, et al.Intravenous autologous bone marrow mononuclear cells for ischemic stroke.Ann Neurol. 2011;70(1):59-69.
37. Honmou O, Houkin K, Matsunaga T, et al.Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke.Brain. 2011;134(Pt 6):1790-1807.
38. Honmou O.Cell therapy for stroke.Rinsho Shinkeigaku. 2013;53(11):1175-1176.
39. Bringas ML, Suarez C, Sanchez C, et al. Cognitive changes after stem cell transplantation in a patient with subcortical stroke. BMJ Case Rep.2011: doi 10.1136/bcr.03.2011.3944.
40. Suárez-Monteagudo C, Hernández-Ramírez P, Alvarez-González L, et al.Autologous bone marrow stem cell neurotransplantation in stroke patients. An open study.Restor Neurol Neurosci. 2009;27(3):151-161.
41. Battistella V, de Freitas GR, da Fonseca LM, et al. Safety of autologous bone marrow mononuclear cell transplantation in patients with nonacute ischemic stroke.Regen Med. 2011;6(1):45-52.
42. Lee JS, Hong JM, Moon GJ, Lee PH, Ahn YH, Bang OY; STARTING collaborators. A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke.Stem Cells. 2010;28(6):1099-1106.
43. Kim SJ, Moon GJ, Chang WH, Kim YH, Bang OY.STARTING-2 (stem cell application researches and trials in neurology-2) collaborators. Intravenous transplantation of mesenchymal stem cells preconditioned with early phase stroke serum: current evidence and study protocol for a randomized trial.Trials. 2013;14(1):317-328.
44. Kondziolka D, Wechsler L, Goldstein S, et al.Transplantation of cultured human neuronal cells for patients with stroke.Neurology. 2000;55:565-569.
45. Kondziolka D, Steinberg GK, Wechsler L, et al.Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial.J Neurosurg. 2005;103(1):38-45.
46 46. Meltzer CC, Kondziolka D, Villemagne VL, et al. Serial [18F] fluorodeoxyglucose positron emission tomography after human neuronal implantation for stroke.Neurosurgery. 2001;49(3):586-591.
47. Stilley CS, Ryan CM, Kondziolka D, Bender A, DeCesare S, Wechsler L. Changes in cognitive function after neuronal cell transplantation for basal ganglia stroke.Neurology. 2004;63(7):1320-1322.
48. Nelson PT, Kondziolka D, Wechsler L, et al.Clonal human (hNT) neuron grafts for stroke therapy: neuropathology in a patient 27 months after implantation.Am J Pathol. 2002;160(4):1201-1206.
49. Jiang Y, Zhu W, Zhu J, Wu L, Xu G, Liu X.Feasibility of delivering mesenchymal stem cells via catheter to the proximal end of the lesion artery in patients with stroke in the territory of the middle cerebral artery.Cell Transplant. 2013;22(12):2291-2298.
50. Liu X, Ye R, Yan T, et al.Cell based therapies for ischemic stroke: from basic science to bedside.Prog Neurobiol. 2014;115:92-115.
51. Chen DC, Lin SZ, Fan JR, et al.Intracerebral implantation of autologous peripheral blood stem cells in stroke patients: a randomized phase II study.Cell Transplant. 2014; 23(12):1599-1612.
52. Wang L, Ji H, Li M, et al.Intrathecal administration of autologous CD34 positive cells in patients with past cerebral infarction: a safety study.ISRN Neurol. 2013;2013:128591.
53. Savitz SI, Dinsmore J, Wu J, Henderson GV, Stieg P, Caplan LR.Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: a preliminary safety and feasibility study.Cerebrovasc Dis. 2005;20(2):101-107.
54. Bhasin A, Srivastava MV, Mohanty S, Bhatia R, Kumaran SS, Bose S.Stem cell therapy: a clinical trial of stroke.Clin Neurol Neurosurg. 2013;115(7):1003-1108.
55. Chen L, Xi H, Huang H, et al.Multiple cell transplantation based on an intraparenchymal approach for patients with chronic phase stroke.Cell Transplant. 2013;22(Suppl 1):S83-S91.
56. Qiao LY, Huang FJ, Zhao M, et al.A two-year follow-up study of co-transplantation with neural stem/precursor cells and mesenchymal stromal cells in ischemic stroke patients.Cell Transplant. 2014;23(Suppl 1):S65-S72.
57. Doycheva D, Shih G, Chen H, Applegate R, Zhang JH, Tang J.Granulocyte-colony stimulating factor in combination with stem cell factor confers greater neuroprotection after hypoxic-ischemic brain damage in the neonatal rats than a solitary treatment.Transl Stroke Res. 2013;4(2):171-178.
58. Le Q, Qu Y, Tao Y, Zhu S.Effects of repetitive transcranial magnetic stimulation on hand function recovery and excitability of the motor cortex after stroke: a meta-analysis.Am J Phys Med Rehabil. 2014;93(5):422-430.
59. Hosomi K, Kishima H, Oshino S, et al.Cortical excitability changes after high-frequency repetitive transcranial magnetic stimulation for central poststroke pain.Pain. 2013;154(8):1352-1357.
60. Meinzer M, Lindenberg R, Sieg MM, Nachtigall L, Ulm L, Flöel A.Transcranial direct current stimulation of the primary motor cortex improves word-retrieval in older adults.Front Aging Neurosci. 2014;6:253.
61. Monti A, Ferrucci R, Fumagalli M, et al.Transcranial direct current stimulation (tDCS) and language.J Neurol Neurosurg Psychiatry. 2013;84(8):832-842.
62. Grefkes C, Fink GR.Disruption of motor network connectivity post-stroke and its noninvasive neuromodulation.Curr Opin Neurol. 2012;25(6):670-675.
63. Mazzoleni S, Sale P, Franceschini M, et al.Effects of proximal and distal robot-assisted upper limb rehabilitation on chronic stroke recovery.NeuroRehabilitation. 2013;33(1):33-39.
64. Hu XL, Tong KY, Wei XJ, Rong W, Susanto EA, Ho SK.The effects of post-stroke upper-limb training with an electromyography (EMG)-driven hand robot.J Electromyogr Kinesiol. 2013;23(5):1065-1074.
65. Godfrey SB, Holley RJ, Lum PS.Clinical effects of using HEXORR (hand exoskeleton rehabilitation robot) for movement therapy in stroke rehabilitation.Am J Phys Med Rehabil. 2013;92(11):947-958.
66. Koopman B, van Asseldonk EH, van der Kooij H. Selective control of gait subtasks in robotic gait training: foot clearance support in stroke survivors with a powered exoskeleton.J Neuroeng Rehabil. 2013;10:3.
67. Klamroth-Marganska V, Blanco J, Campen K, et al.Three-dimensional, task-specific robot therapy of the arm after stroke: a multicentre, parallel-group randomised trial.Lancet Neurol. 2014;13(2):159-166.
68. Hochberg LR, Bacher D, Jarosiewicz B, et al.Reach and grasp by people with tetraplegia using a neurally controlled robotic arm.Nature. 2012;485(7398):372-375.
69. Huang H, Chen L, Sanberg P.Cell therapy from bench to bedside translation in CNS neurorestoratology era.Cell Med. 2010;1(1):15-46.
70. Shehadah A, Chen J, Pal A, et al.Human placenta-derived adherent cell treatment of experimental stroke promotes functional recovery after stroke in young adult and older rats.PLoS One. 2014;9(1):e86621.
71. Sun C, Sun H, Wu S, et al.Conditional ablation of neuroprogenitor cells in adult mice impedes recovery of poststroke cognitive function and reduces synaptic connectivity in the perforant pathway.J Neurosci. 2013;33(44):17314-17325.
72. Hermann DM, Chopp M.Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation.Lancet Neurol. 2012;11(4):369-380.
73. Daadi MM, Li Z, Arac A, et al.Molecular and magnetic resonance imaging of human embryonic stem cell-derived neural stem cell grafts in ischemic rat brain.Mol Ther. 2009;17:1282-1291.
74. Bühnemann C, Scholz A, Bernreuther C, et al.Neuronal differentiation of transplanted embryonic stem cell-derived precursors in stroke lesions of adult rats.Brain. 2006;129:3238-3248.
75. Hayashi J, Takagi Y, Fukuda H, et al.Primate embryonic stem cell-derived neuronal progenitors transplanted into ischemic brain.J Cereb Blood Flow Metab. 2006;26:906-914.
76. Chen SJ, Chang CM, Tsai SK, et al.Functional improvement of focal cerebral ischemia injury by subdural transplantation of induced pluripotent stem cells with fibrin glue.Stem Cells Dev. 2010;19:1757-1767.
77. Zhang ZG, Jiang Q, Zhang R, et al.Magnetic resonance imaging and neurosphere therapy of stroke in rat.Ann Neurol. 2003;53:259-263.
78. Kuroda S, Shichinohe H, Houkin K, Iwasaki Y.Autologous bone marrow stromal cell transplantation for central nervous system disorders - recent progress and perspective for clinical application.J Stem Cell Regen Med. 2011;7:1-12.
79. Uccelli A, Moretta L, Pistoia V.Mesenchymal stem cells in health and disease.Nat Rev Immunol. 2008;8:726-736.
80. Zhang L, Li Y, Romanko M, et al.Different routes of administration of human umbilical tissue-derived cells improve functional recovery in the rat after focal cerebral ischemia.Brain Res. 2012;1489:104-112.
81. Janowski M, Lyczek A, Engels C, et al.Cell size and velocity of injection are major determinants of the safety of intracarotid stem cell transplantation.J Cereb Blood Flow Metab. 2013;33(6):921-927.
82. Byun JS, Kwak BK, Kim JK, Jung J, Ha BC, Park S.Engraftment of human mesenchymal stem cells in a rat photothrombotic cerebral infarction model: comparison of intra-arterial and intravenous infusion using MRI and histological analysis.J Korean Neurosurg Soc. 2013;54(6):467-476.
83. Ruan GP, Han YB, Wang TH, et al.Comparative study among three different methods of bone marrow mesenchymal stem cell transplantation following cerebral infarction in rats.Neurol Res. 2013;35(2):212-220.
84. Yang B, Migliati E, Parsha K, et al.Intra-arterial delivery is not superior to intravenous delivery of autologous bone marrow mononuclear cells in acute ischemic stroke.Stroke. 2013;44(12):3463-3472.
85. Wei N, Yu SP, Gu X, et al.Delayed intranasal delivery of hypoxic-preconditioned bone marrow mesenchymal stem cells enhanced cell homing and therapeutic benefits after ischemic stroke in mice.Cell Transplant. 2013;22:977-991.
86. Barbosa da Fonseca LM, Battistella V, de Freitas GR, et al. Early tissue distribution of bone marrow mononuclear cells after intra-arterial delivery in a patient with chronic stroke.Circulation. 2009;120(6):539-541.
87. Correa PL, Mesquita CT, Felix RM, et al.Assessment of intra-arterial injected autologous bone marrow mononuclear cell distribution by radioactive labeling in acute ischemic stroke.Clin Nucl Med. 2007; 32(11):839-841.
88. Chang DJ, Oh SH, Lee N, et al.Contralaterally transplanted human embryonic stem cell-derived neural precursor cells (ENStem-A) migrate and improve brain functions in stroke-damaged rats.Exp Mol Med. 2013;15(45):e53.
89. Dai J, Li SQ, Qiu YM, et al.Migration of neural stem cells to ischemic brain regions in ischemic stroke in rats.Neurosci Lett. 2013;552: 124-128.
90. Shichinohe H, Yamauchi T, Saito H, Houkin K, Kuroda S.Bone marrow stromal cell transplantation enhances recovery of motor function after lacunar stroke in rats.Acta Neurobiol Exp (Wars). 2013;73(3):354-363.
91. Cai H, Zhang Z, Yang GY.Preconditioned stem cells: a promising strategy for cell-based ischemic stroke therapy.Curr Drug Targets. 2014;15(8):771-779.
92. Yu SP, Wei Z, Wei L.Preconditioning strategy in stem cell transplantation therapy.Transl Stroke Res. 2013;4(1):76-88.
[1] Lin Chen, Tao Chen, Gengsheng Mao, Baodong Chen, Mingchang Li, Hongbo Zhang, Haitao Xi, Xiaochun She, Zhouping Tang, Ping Zhang, Zhiqiang Zhang, Li Cong, Yijun Bao, Xiaofeng Yang, Siyuan Zhao, Chao He, Liang Wen, Ping Zhang, Mengzhou Xue, Mengzhou Xue. Clinical neurorestorative therapeutic guideline for brainstem hemorrhage (2020 China version)[J]. Journal of Neurorestoratology, 2020, 8(4): 232-240.
[2] Xiaoling Guo, Qun Xue, Jianhua Zhao, Yi Yang, Yang Yu, Dezhong Liu, Jing Liu, Wenwu Yang, Linsen Mu, Ping Zhang, Tianyi Wang, Hongyan Han, Shoufeng Liu, Yuhua Zhu, Tao Wang, Chuanqiang Qu, Chuanqiang Qu. Clinical diagnostic and therapeutic guidelines of stroke neurorestoration (2020 China version)[J]. Journal of Neurorestoratology, 2020, 8(4): 241-251.
[3] Yi Yang, Long Xu, Rong Xie, Yuanyuan Dang, Xiaoyu Xia, Jianghong He, Jizong Zhao. A meta-analysis on the efficiency of the time window of hyperbaric oxygen treatment on disorders of consciousness in China[J]. Journal of Neurorestoratology, 2020, 8(4): 270-280.
[4] Xinyu Wang, Nan Sun, Xiangqi Meng, Meng Chen, Chuanlu Jiang, Jinquan Cai. Review of clinical nerve repair strategies for neurorestoration of central nervous system tumor damage[J]. Journal of Neurorestoratology, 2020, 8(3): 172-181.
[5] Yunliang Wang, Xiaoling Guo, Jun Liu, Zuncheng Zheng, Ying Liu, Wenyong Gao, Juan Xiao, Yanqiu Liu, Yan Li, Manli Tang, Linlin Wang, Lin Chen, Di Chen, Deqiang Guo, Fei Liu, Weidong Chen, Baomin Chan, Bo Zhou, Aibing Liu, Gengsheng Mao, Hongyun Huang. Olfactory ensheathing cells in chronic ischemic stroke: A phase 2, double-blind, randomized, controlled trial[J]. Journal of Neurorestoratology, 2020, 8(3): 182-193.
[6] Hongyun Huang, Lin Chen, Gengsheng Mao, Hari Shanker Sharma. Clinical neurorestorative cell therapies: Developmental process, current state and future prospective[J]. Journal of Neurorestoratology, 2020, 8(2): 61-82.
[7] Miaomiao Zhuang, Qingheng Wu, Feng Wan, Yong Hu. State-of-the-art non-invasive brain–computer interface for neural rehabilitation: A review[J]. Journal of Neurorestoratology, 2020, 8(1): 12-25.
[8] Jiancheng Zang,Sihe Qin,Vigneshwaran P,Lei Shi,Xulei Qin. The treatment of neurotrophic foot and ankle deformity of spinal bifida: 248 cases in single center[J]. Journal of Neurorestoratology, 2019, 7(3): 153-160.
[9] Weiwei Zhao,Chuanguang Ju,Daozhen Wang,Huifen Shen. Clinical observation of effects of ultrashort wave therapy combined with acupuncture and rehabilitation training in the treatment of patients with dysphagia after stroke[J]. Journal of Neurorestoratology, 2019, 7(3): 136-142.
[10] Xiaoling Guo, Xin Wang, Yan Li, Bo Zhou, Weidong Chen, Lihua Ren. Olfactory ensheathing cell transplantation improving cerebral infarction sequela: a case report and literature review[J]. Journal of Neurorestoratology, 2019, 7(2): 82-88.
[11] Shina Gu, Xiaodan Li, Lin Zhao, Huicong Ren, Chendi Pei, Wenqiang Li, Junlin Mu, Jinggui Song, Zhaohui Zhang. Decreased Npas4 expression in patients with post-stroke depression[J]. Journal of Neurorestoratology, 2019, 7(2): 101-108.
[12] Qiang Ao, Juan Xiao, Yanqiu Yu, Gengsheng Mao, Qingyan Zou, Wenyong Gao, Hongyun Huang. Standards for the culture and quality control of umbilical cord mesenchymal stromal cells for neurorestorative clinical application (2017)[J]. Journal of Neurorestoratology, 2018, 6(1): 11-15.
[13] Gengsheng Mao, Yunliang Wang, Xiaoling Guo, Jun Liu, Zuncheng Zheng, Lin Chen. Neurorestorative effect of olfactory ensheathing cells and Schwann cells by intranasal delivery for patients with ischemic stroke: design of a multicenter randomized double-blinded placebo-controlled clinical study[J]. Journal of Neurorestoratology, 2018, 6(1): 74-80.
[14] Andrey S. Bryukhovetskiy. Translational experience of 28 years of use of the technologies of regenerative medicine to treat complex consequences of the brain and spinal cord trauma: Results, problems and conclusions[J]. Journal of Neurorestoratology, 2018, 6(1): 99-114.
[15] Hongyun Huang, Hari Shanker Sharma, Lin Chen, Ali Otom, Ziad M. Al Zoubi, Hooshang Saberi, Dafin F. Muresanu, Xijing He. Review of clinical neurorestorative strategies for spinal cord injury: Exploring history and latest progresses[J]. Journal of Neurorestoratology, 2018, 6(1): 171-178.